Nancy Schoendorf Adamas Pharmaceuticals Inc

As of September 16, 2016


Nancy Schoendorf Net Worth

  • Net worth is estimated to be at least $751.29M
  • Owns at least 4,319,796 units of Adamas Pharmaceuticals Inc stock
  • Sold an estimated value of $4.55M in the last 2 years at Adamas Pharmaceuticals Inc

Nancy Schoendorf Trading

  • Largest purchase of shares was 1,841,312 units , worth over $4.8M on April 16, 2014
  • Largest sale of shares was 119,556 units , worth over $2.15M on June 1, 2015
  • In total has made about 12 transactions over 2 years
  • Usually trades in September, with the busiest year in 2015

MDV IX LP, Seventh MDV Partners LLC, Ninth MDV Partners LLC, JONATHAN FEIBER, NANCY SCHOENDORF, MDV ENF VII A LP, MDV ENF VII B LP, MDV VII Leaders Fund LP, MDV VII LP

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Nancy Schoendorf Mailing Address

  • Mailing address is C/o Mohr Davidow Ventures 3000 Sand Hill Rd Menlo Park CA 94025 CA

Adamas Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Stock Awards
Option Awards
Other Compensation
Total
Neil F. McFarlane 2020 $604,167 $31,300 $431,300 $199,000 $233,220 $193,954 $1,692,941
Neil F. McFarlane 2019 $182,292 $ $125,200 $781,250 $957,325 $34,575 $2,080,642
Vijay Shreedhar, Ph.D. 2020 $418,034 $21,700 $224,600 $55,100 $64,367 $58,498 $842,299
Vijay Shreedhar, Ph.D. 2019 $252,344 $ $130,200 $321,063 $397,513 $128,974 $1,230,094
Christopher B. Prentiss 2020 $386,667 $20,000 $184,000 $23,200 $ $6,912 $620,779
Christopher B. Prentiss 2019 $358,333 $ $184,000 $245,188 $298,980 $7,140 $1,093,641
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1328143/000132814321000033/adms2021proxystatement.htm

Adamas Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 6,200 units sold on June 23, 2021 by Vijay Shreedhar worth over $31.98K
  • In the last 7 years, insiders at Adamas Pharmaceuticals Inc sold an estimated value of $27.45M and bought an estimated value of $19.72M
  • The most active traders are Gregory Went, Chief Executive Officer,  William Ericson, Director,  and Ivan Lieberburg, Director
  • Insider trading is most common in June, with the busiest year in 2015

Adamas Pharmaceuticals Inc Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1